Bringing the fundamentals into focus…
Back to X4 Pharmaceuticals, Inc.
How X4 Pharmaceuticals, Inc. stacks up
XFOR · against 370 other Healthcare companies of similar size
Valuation
75/ 100
Above the middle of the pack.
Ranked #95 of 371 · scores higher than 74% of peers
Bars: peers in each 10-point band of the valuation score32 peers with a valuation score of 70–79, including XFOR · Click a bar to see the companies
Why valuation scores 75?
Weighted metrics compared with all Healthcare companies.Mainly thanks to its earnings yield, which is stronger than most Healthcare peers.
- Negative (a loss or cash outflow), so it counts as zero whatever the share price. EBITDA yield: -43.0% vs peer median 4.0%
- Negative (a loss or cash outflow), so it counts as zero whatever the share price. Free cash flow yield: -28.2% vs peer median 0.0%
- higher earnings for the price paid: stronger than 100% of peers. Earnings yield: 45.1% vs peer median 1.5%
Metric by metric
Position: dot = XFOR, ranked from the worst peer (left) to the best (right); tick = middle, shaded = middle half of peers.| Metric | XFOR | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Earnings yieldHigher is better · 355 reported | 45.1% | -0.2% | 100% | 30% | |
| EBITDA yieldHigher is better · 376 reported | -43.0% | 2.2% | 11% | 50% | |
| Free cash flow yieldHigher is better · 183 reported | -28.2% | -9.2% | 19% | 20% | |
| Book yieldHigher is better · 363 reported | 51.0% | 50.9% | 50% | Context only |
Ranking by valuation score
Top 5 and the companies ranked around XFOR| Rank | Company | Market cap | Valuation | Overall |
|---|---|---|---|---|
| 1 | 3.5B HKD (≈$451M) | 99 | 51 | |
| 1 | 1.4B HKD (≈$181M) | 99 | 61 | |
| 1 | 2.9B HKD (≈$365M) | 99 | 84 | |
| 1 | 89.9B JPY (≈$611M) | 99 | 68 | |
| 1 | 3.1B HKD (≈$396M) | 99 | 61 | |
| 88 | 3.4B SEK (≈$337M) | 76 | 45 | |
| 88 | 528M USD | 76 | 58 | |
| 95 | 655M AUD (≈$432M) | 75 | 62 | |
| 95 | 464M USD | 75 | 53 | |
| 95 | 314M USD | 75 | 56 | |
| 98 | 3.0B HKD (≈$388M) | 74 | 64 | |
| 98 | 30.4B JPY (≈$206M) | 74 | 57 | |
| 98 | 14.3B TRY (≈$428M) | 74 | 60 | |
| 101 | 3.5B CNY (≈$491M) | 73 | 79 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score